Assignee
KADMON CORP LLC
US·22 granted patents·25 pending applications·71 citations·filing 2012–2025
Top patents by PatentIndex Score
47 records- 0193US10696660B2Rho kinase inhibitorsKADMON CORP LLC·Filed 2019·Granted Jun 30, 2020·17 cites·3 claims
- 0293US10183931B2Rho kinase inhibitorsKADMON CORP LLC·Filed 2017·Granted Jan 22, 2019·18 cites·9 claims
- 0392US9815820B2Rho kinase inhibitorsKADMON CORP LLC·Filed 2013·Granted Nov 14, 2017·22 cites·14 claims
- 0485US11311541B2Treatment of GVHDKADMON CORP LLC·Filed 2015·Granted Apr 26, 2022·4 cites·2 claims
- 0584US10407502B2Immunomodulatory agentsKADMON CORP LLC·Filed 2015·Granted Sep 10, 2019·7 cites·7 claims
- 0681US11071735B2Treatment of inflammatory conditions and autoimmune diseases with glucose uptake inhibitorsKADMON CORP LLC·Filed 2018·Granted Jul 27, 2021·2 cites·36 claims
- 0778US2026034127A1Treatment of gvhdKADMON CORP LLC·Filed 2024·Application pending·0 cites
- 0876US2023338524A1Human Anti-VEGFR-2/KDR AntibodiesKADMON CORP LLC·Filed 2023·Application pending·0 cites
- 0970US11952369B2Belumosudil metabolites and uses thereof in the treatment of chronic graft-versus-host diseaseKADMON CORP LLC·Filed 2023·Granted Apr 9, 2024·0 cites·2 claims
- 1070US2024360085A1Glucose Uptake InhibitorsKADMON CORP LLC·Filed 2024·Application pending·0 cites
- 1169US11479533B2Inhibitors of Rho associated coiled-coil containing protein kinaseKADMON CORP LLC·Filed 2018·Granted Oct 25, 2022·1 cites·20 claims
- 1269US2024190827A1Inhibitors of Rho Associated Coiled-Coil Containing Protein KinaseKADMON CORP LLC·Filed 2024·Application pending·0 cites
- 1369US2025136693A1Anti-PD-1 Antibodies and Fusion ProteinsKADMON CORP LLC·Filed 2024·Application pending·0 cites
- 1468US11633475B2Human anti-VEGFR-2/KDR antibodiesKADMON CORP LLC·Filed 2020·Granted Apr 25, 2023·0 cites·8 claims
- 1568US2022395501A1Treatment of gvhdKADMON CORP LLC·Filed 2022·Application pending·0 cites
- 1667US2024350493A1Methods of Administering Belumosudil in Combination with CYP3A Inducers and/or Proton Pump InhibitorsKADMON CORP LLC·Filed 2024·Application pending·0 cites
- 1766US2023174519A1Inhibitors of Rho Associated Coiled-Coil Containing Protein KinaseKADMON CORP LLC·Filed 2023·Application pending·0 cites
- 1866US2023381179A1Methods of Treating Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell TransplantationKADMON CORP LLC·Filed 2023·Application pending·0 cites
- 1966US2021147391A1Rho kinase inhibitorsKADMON CORP LLC·Filed 2020·Application pending·0 cites
- 2064US12097202B2Methods of administering Belumosudil for treatment of chronic graft versus host diseaseKADMON CORP LLC·Filed 2023·Granted Sep 24, 2024·0 cites·6 claims
- 2163US2024024322A1Methods of Administering Belumosudil in Combination with CYP3A Inducers and/or Proton Pump InhibitorsKADMON CORP LLC·Filed 2023·Application pending·0 cites
- 2263US2024408095A1Method of Administering Belumosudil for Treatment of Chronic Graft Versus Host DiseaseKADMON CORP LLC·Filed 2024·Application pending·0 cites
- 2363US2024262810A1Belumosudil Metabolites and Uses Thereof In The Treatment of Chronic Graft-Versus-Host DiseaseKADMON CORP LLC·Filed 2024·Application pending·0 cites
- 2463US2025255867A1Belumosudil for Treating Chronic Lung Allograft DysfunctionKADMON CORP LLC·Filed 2023·Application pending·0 cites
- 2563US2026027116A1Methods of Treating Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell TransplantationKADMON CORP LLC·Filed 2025·Application pending·0 cites
- 2659US10988484B2Glucose uptake inhibitorsKADMON CORP LLC·Filed 2019·Granted Apr 27, 2021·0 cites·7 claims
- 2758US10588968B2Human anti-VEGFR-2/KDR antibodiesKADMON CORP LLC·Filed 2015·Granted Mar 17, 2020·0 cites·13 claims
- 2858US2026097036A1Liquid Formulation of BelumosudilKADMON CORP LLC·Filed 2023·Application pending·0 cites
- 2955US12030857B2Glucose uptake inhibitorsKADMON CORP LLC·Filed 2019·Granted Jul 9, 2024·0 cites·2 claims
- 3055US11926596B2Inhibitors of Rho associated coiled-coil containing protein kinaseKADMON CORP LLC·Filed 2018·Granted Mar 12, 2024·0 cites·18 claims
- 3155US2023312724A1B7-H4 Antibodies and Anti-B7-H4 Antibody/IL-15 Fusion ProteinsKADMON CORP LLC·Filed 2022·Application pending·0 cites
- 3254US11613531B2Inhibitors of RHO associated coiled-coil containing protein kinaseKADMON CORP LLC·Filed 2018·Granted Mar 28, 2023·0 cites·17 claims
- 3354US2024277713A1Methods of Administering Belumosudil for Treatment of Chronic Graft Versus Host Disease in Patient SubpopulationsKADMON CORP LLC·Filed 2024·Application pending·0 cites
- 3453US10273248B2Glucose uptake inhibitorsKADMON CORP LLC·Filed 2016·Granted Apr 30, 2019·0 cites·16 claims
- 3553US2016271089A1Methods and compositions for oral delivery of ftsKADMON CORP LLC·Filed 2016·Application pending·0 cites
- 3653US2024059775A9Immunomodulatory agentsKADMON CORP LLC·Filed 2020·Application pending·0 cites
- 3753US2015010545A1Methods for treatment of breast cancer nonresponsive to trastuzumabKADMON CORP LLC·Filed 2012·Application pending·0 cites
- 3852US2023416363A1Anti-PD-1 Antibodies and Fusion ProteinsKADMON CORP LLC·Filed 2021·Application pending·0 cites
- 3951US10364291B2Human anti-VEGFR-2/KDR antibodiesKADMON CORP LLC·Filed 2018·Granted Jul 30, 2019·0 cites·20 claims
- 4051US10023640B2Human anti-VEGFR-2/KDR antibodiesKADMON CORP LLC·Filed 2013·Granted Jul 17, 2018·0 cites·34 claims
- 4151US2024024323A1Methods of Administering Belumosudil for Treatment of Chronic Graft Versus Host Disease in Patient SubpopulationsKADMON CORP LLC·Filed 2023·Application pending·0 cites
- 4246US10125144B2Rho kinase inhibitorsKADMON CORP LLC·Filed 2014·Granted Nov 13, 2018·0 cites·8 claims
- 4344US9586940B2Methods for treatment of breast cancer nonresponsive to trastuzumabKADMON CORP LLC·Filed 2015·Granted Mar 7, 2017·0 cites·10 claims
- 4439US2018244779A1Immunomodulatory agentsKADMON CORP LLC·Filed 2016·Application pending·0 cites
- 4539US2015238601A1Treatment of ocular disordersKADMON CORP LLC·Filed 2013·Application pending·0 cites
- 4633US10729691B2Treatment of infectious diseases with glucose uptake inhibitorsKADMON CORP LLC·Filed 2016·Granted Aug 4, 2020·0 cites·9 claims
- 4729US10080752B2Treatment of brain and central nervous system tumorsKADMON CORP LLC·Filed 2015·Granted Sep 25, 2018·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when KADMON CORP LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →